Nice, France

Fanny Astruc

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Galderma S.a.. Active years: 2014.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fanny Astruc: Innovator in Dermatological Treatments

Introduction

Fanny Astruc is a notable inventor based in Nice, France. She has made significant contributions to the field of dermatology through her innovative work. Her research focuses on developing effective treatments for various skin conditions.

Latest Patents

Fanny Astruc holds a patent for a dermatological cream-gel that contains avermectin compounds. This pharmaceutical composition is particularly useful for treating conditions such as rosacea. The formulation includes an oily phase dispersed in an aqueous phase using a non-surfactant polymeric emulsifier. The oils used in the cream-gel have a melting point below 30°C and are free of solid fats with a melting point above 30°C. This innovative approach provides a physiologically acceptable medium for effective treatment.

Career Highlights

Throughout her career, Fanny has demonstrated a commitment to advancing dermatological science. Her work has led to the development of formulations that improve patient outcomes. She is associated with Galderma S.A., a company known for its focus on dermatological products.

Collaborations

Fanny has collaborated with several professionals in her field, including Laurent Fredon and Sandrine Orsoni. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Fanny Astruc is a pioneering inventor whose work in dermatological cream-gels has the potential to transform treatment options for skin conditions. Her innovative approach and dedication to research continue to make a significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…